Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,393,075
+$153,156 QoQ
Shares Held
3,847
+9.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#1,479
of 3,140 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Northern Financial Advisors Inc holds $8,250,442 across 7 Drug Manufacturers - General names. AMGN ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,910 | $2,290,911 | |
| 2 | AMGN |
Amgen Inc
This page
|
3,847 | $1,393,075 | |
| 3 | JNJ |
Johnson & Johnson
|
4,699 | $1,193,405 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
8,647 | $1,092,461 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,398 | $1,079,143 | |
| 6 | ABBV |
AbbVie Inc.
|
3,712 | $934,087 | |
| 7 | PFE |
Pfizer Inc
|
11,103 | $267,360 |
All Filings in AMGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,393,075 | 3,847 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $1,239,919 | 3,524 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $641,854 | 1,961 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $964,559 | 3,418 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $970,254 | 3,475 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,190,121 | 3,820 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $869,755 | 3,337 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,634,893 | 5,074 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,589,433 | 5,087 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,483,297 | 5,217 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,514,409 | 5,258 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,107,828 | 4,122 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $589,241 | 2,654 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $514,444 | 2,128 | Shares | Sole | 2023-04-27 | |
| No filing history on record for this holder in this stock. | ||||||